Seritage Growth Properties: Q2 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2026. Seritage Growth Properties (SRG) is a taxable C Corporation executing a shareholder-approved "Plan of Sale" to liquidate its real estate portfolio and distribute proceeds. As of the reporting date, the portfolio consists of nine properties (four consolidated, five unconsolidated) totaling approximately 0.8 million square feet of gross leasable area and 139 acres of land. The Company previously operated as a REIT until December 31, 2021.
Key Financial Metrics (Six Months Ended June 30, 2026)
| Metric | Value (in thousands) |
|---|---|
| Total Revenue | $3,924 |
| Net Loss | $(36,446) |
| Net Loss Attributable to Common Shareholders | $(38,896) |
| Net Loss Per Share (Basic & Diluted) | $(0.69) |
| Operating Cash Flow | $(7,291) |
| Investing Cash Flow | $12,004 |
| Financing Cash Flow | $(4,137) |
| Cash and Cash Equivalents | $48,426 |
| Restricted Cash | $14,435 |
| Total Debt (Term Loan) | $49,660 (net) |
| Total Assets | $353,579 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased from $9.3 million in the prior year period to $3.9 million, primarily due to the sale of properties reducing the rental base.
- Impairment Charges: The Company recorded a $15.2 million impairment of real estate assets and a $5.2 million other-than-temporary impairment on investments in unconsolidated entities. This compares to $18.0 million and $8.5 million respectively in the prior year period.
- Expense Reduction: General and administrative expenses dropped significantly to $10.4 million from $21.9 million in the prior year, driven by a $6.5 million severance charge recognized in 2025 that did not recur.
- Debt Restructuring: While the balance sheet shows a $50 million term loan, the Company fully repaid this facility subsequent to the period end (July 2026) using proceeds from new financing.
Outlook, Risks, and Unusual Items
- Going Concern Resolution: Management previously disclosed substantial doubt about the Company's ability to continue as a going concern due to the maturing term loan. This doubt has been alleviated following the execution of a new $15 million term loan and a $25 million revolving credit facility on July 24, 2026, which were used to refinance the maturing debt.
- Asset Sales: The Company continues to execute the Plan of Sale. Subsequent to June 30, 2026, it sold a consolidated property for $3.0 million and received an $8.9 million distribution from an unconsolidated joint venture. An option agreement exists to sell a Dallas asset for approximately $50.8 million, though closing is not guaranteed.
- Internal Control Weaknesses: The Company reported that disclosure controls and procedures were not effective due to material weaknesses in the review of the general ledger and segregation of duties regarding journal entries. Remediation is ongoing.
- Litigation: The Company is defending against a class action lawsuit and multiple derivative lawsuits alleging violations of securities laws and breach of fiduciary duty related to impairment disclosures and internal controls. These actions are currently stayed pending motions to dismiss.
Investor Verification Checklist
- Debt Maturity: Verify the terms and covenants of the new July 2026 financing facilities ($15M term / $25M revolver) and confirm the full payoff of the Berkshire Hathaway term loan.
- Asset Valuation: Review the specific properties triggering the $15.2 million impairment charge and assess the likelihood of future impairments given the "Plan of Sale" strategy.
- Litigation Status: Monitor the status of the stayed securities class action and derivative suits, as a dismissal could impact legal costs and management stability.
- Internal Controls: Track the progress of the remediation plan for material weaknesses in financial reporting controls.
- Sale Execution: Confirm the closing status of the Dallas asset option agreement and the timeline for remaining asset dispositions.